Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JCOG0203: R-CHOP-21 vs R-CHOP-14 for Low-grade B-cell Lymphoma
NCT00147121Phase 3Completed
- Start
- Sep 2002
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone in B cell lymphoma. Started Sep 2002; status: completed.
02
Drugs
rituximabcyclophosphamidedoxorubicinvincristineprednisolone
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00147121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147121.